Category:
Active Pharmaceutical Ingredients
CAS NO:
491833-29-5
Standard:
In-house Standards,
Rare Disease Gaucher Disease
Eliglustat is a substrate reduction therapy agent used in Gaucher disease. It functions by inhibiting glucosylceramide synthase. The molecular formula is C20H29NO2 with CAS No. 851453-73-1.
Contraindicated in patients with severe hepatic impairment. Store below 25°C in dry conditions. Requires genetic testing for CYP2D6 metabolism status prior to administration.